Have a question or want to speak with a team member?
Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.
Apr 10, 2024
Apr 10, 2024
OCC’s interview with Stephanie Gill
Apr 7, 2024
Apr 7, 2024
Ovarian cancer prevention can save lives now
Ovarian Cancer Canada establishes Ovarian Cancer Prevention Task Force to help decrease incidence of the disease
Dec 14, 2023
Ovarian Cancer Canada applauds the government’s commitment to women’s health
We are grateful and proud to announce that Ovarian Cancer Canada (OCC) is one of the recipients of the Government of Canada’s Strategic Science Fund (SSF).
Dec 4, 2023
A strategic partnership of $1.2M for ovarian cancer treatments
Ovarian Cancer Canada (OCC) and the Cancer Research Society (CRS) jointly announce the launch of the "Bridging the Gap for Ovarian Cancer Treatments Grants Competition".
Mar 15, 2023
Mar 15, 2023
Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources
Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer (Q-CROC) are teaming up to optimize the support available to women affected by ovarian cancer in Quebec.
Feb 15, 2023
Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island
Women living in Prince Edward Island (PEI) now have access to precision treatments for ovarian cancer, thanks to Ovarian Cancer Canada’s advocacy efforts.
Feb 8, 2023
Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world
Every 5 hours, we lose someone we love to ovarian cancer in Canada. Ovarian cancer is the most fatal women’s cancer and sadly, one in two diagnosed do not live to see another five years.
Dec 16, 2022
Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative
Two funded clinical trials, though different in their approach and focus, share a dedication to exploring innovative treatment pathways and a made-in-Canada pedigree.
Nov 29, 2022
Research knows no bounds
Ovarian Cancer Canada takes a multi-pronged approach to ensure that all types of the disease, even the rarest ones, are prioritized to ensure that everyone benefits from the best available science as quickly as possible.